Find a Specialist by Name | Page 13 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Find a Specialist by Name

This is a working list in progress of bone marrow failure specialists who are seeing new patients for treatment or consultation.

It’s important for patients to seek consultation with physicians who have experience working with bone marrow failure disease. We’ve developed this interactive map of physician specialists in bone marrow failure disease who have worked with the Aplastic Anemia and MDS International Foundation in a significant way as speakers, writers, editors, and/or advisors. This map will allow you to search for physicians in your area by location using the zoom-in feature, by zip code, or by disease area utilizing the dropdowns provided below.

Please note:

  • This list is not comprehensive and there may be specialists in your area who have not yet been included.
  • Physicians may move to another institution for various reasons and may no longer be at the location noted on this map.
  • The map will be updated as often as possible.

If you do not find a physician on this map, please contact our Patient Educator Leigh Clark at clark@aamds.org for assistance locating a specialist in your area.

Name Institution City State Country Disease Expertise
Carlos E. Vigil, MD University of Iowa Clinic and Hospitals Iowa City Iowa United States
  • Acute Myeloid Leukemia (AML)
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelomonocytic Leukaemia (CMML)
  • Myelodysplastic Syndromes (MDS)
Anem Waheed, MD, MPH Weill Cornell Medicine New York New York United States
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Alison R. Walker, MD H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida Tampa Florida United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
Matthew Walter, MD Washington University - Barnes Jewish Hospital St. Louis Missouri United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
Trent Peng Wang, DO University of Miami Health System - Sylvester Comprehensive Cancer Center Miami Florida United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pure Red Cell Aplasia (PRCA)
Erica Warlick, MD University of Minnesota Medical Center Minneapolis Minnesota United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Ilene Weitz, MD University of Southern California Los Angeles California United States
  • Aplastic Anemia
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Peter Westervelt, MD, PhD Siteman Cancer Center St. Louis Missouri United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Marcin Wlodarski, MD, PhD St Jude Children’s Research Hospital Memphis Tennessee United States
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pediatric
Zhuoer Xie, MD, MS Moffitt Cancer Center Tampa Florida United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Chronic Myelomonocytic Leukaemia (CMML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Mina L. Xu, MD Yale University School of Medicine New Haven Connecticut United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Abdulraheem Yacoub, MD University of Kansas Medical Center Kansas City Kansas United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Eric Yang, MD Ronald Reagan University of California, Los Angeles Medical Center Los Angeles California United States
  • Acute Myeloid Leukemia (AML)
  • Myeloproliferative Neoplasms (MPN)
Jay Yang, MD Karmanos Cancer Institute Detroit Michigan United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Musa Yilmez, MD MD Anderson Cancer Center Houston Texas United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Neal Young, MD National Heart, Lung, and Blood Institute - National Institutes of Health Bethesda Maryland United States
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pediatric
Amer Zeidan, MBBS Yale University and Yale Cancer Center New Haven Connecticut United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Joshua Zeidner, MD Chapel Hill North Carolina United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Tian Yi Zhang, MD, PhD Stanford University School of Medicine Stanford California United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)